Exact Mass: 521.058625

Exact Mass Matches: 521.058625

Found 23 metabolites which its exact mass value is equals to given mass value 521.058625, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

5-Guanylylmethylenediphosphonate

Guanosine 5-monophosphate, monoanhydride with (phosphonomethyl)phosphonic acid

C11H18N5O13P3 (521.0113968)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents

   

4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol

[({[(2R,3S,4R,5R)-3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy][(2R,3S)-2,3,4-trihydroxy-3-methylbutoxy]phosphinic acid

C14H25N3O14P2 (521.081173)


4-diphosphocytidyl-2-c-methyl-d-erythritol is a member of the class of compounds known as pyrimidine ribonucleoside diphosphates. Pyrimidine ribonucleoside diphosphates are pyrimidine ribonucleotides with diphosphate group linked to the ribose moiety. 4-diphosphocytidyl-2-c-methyl-d-erythritol is soluble (in water) and a moderately acidic compound (based on its pKa). 4-diphosphocytidyl-2-c-methyl-d-erythritol can be found in a number of food items such as pepper (c. chinense), pistachio, chestnut, and lupine, which makes 4-diphosphocytidyl-2-c-methyl-d-erythritol a potential biomarker for the consumption of these food products. 4-diphosphocytidyl-2-c-methyl-d-erythritol may be a unique E.coli metabolite.

   

6-Thioguanosine-5'- O- triphosphate

({[({[5-(2-amino-6-methylidene-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid

C11H18N5O13P3 (521.0113968)


6-Thioguanosine-5- O- triphosphate is a metabolite of azathioprine. Azathioprine is a purine analogue immunosuppressive drug. It is used to prevent rejection following organ transplantation, and to treat a vast array of autoimmune diseases, including rheumatoid arthritis, pemphigus, inflammatory bowel disease, multiple sclerosis, autoimmune hepatitis, atopic dermatitis, myasthenia gravis, neuromyelitis optica or Devics disease, restrictive lung disease, and others. (Wikipedia)

   

CDP-ME

4-(Cytidine 5-diphospho)-2-C-methyl-D-erythritol

C14H25N3O14P2 (521.081173)


   

Ophrysanin

3,5,7,3,4-Pentahydroxyflavylium 3- (6"-oxalylglucoside)

C23H21O14 (521.0931266)


   

5-[4-[(2S)-2-(1H-Benzimidazol-2-yl)-2-(2-benzothiazolylamino)ethyl]-2-fluorophenyl]-3-isothiazolidinone 1,1-dioxide

5-[4-[(2S)-2-(1H-Benzimidazol-2-yl)-2-(2-benzothiazolylamino)ethyl]-2-fluorophenyl]-3-isothiazolidinone 1,1-dioxide

C25H20FN5O3S2 (521.0991542)


   

[[5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 2,3-dihydroxypropyl hydrogen phosphate,sodium

[[5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 2,3-dihydroxypropyl hydrogen phosphate,sodium

C12H19N3Na2O13P2 (521.0188504)


   

(E)-ethyl 5-(benzyloxy)-6-broMo-1-Methyl-2-(2-(phenylthio)vinyl)-1H-indole-3-carboxylate

(E)-ethyl 5-(benzyloxy)-6-broMo-1-Methyl-2-(2-(phenylthio)vinyl)-1H-indole-3-carboxylate

C27H24BrNO3S (521.0660174000001)


   

chondroitin disaccharide (Di-4S, sodium salt)

chondroitin disaccharide (Di-4S, sodium salt)

C14H21NO15SNa2 (521.0427276)


   

N-(5-Bromo-2-pyridinyl)-2-[[4-(imino-1-pyrrolidinylmethyl)benzoyl]amino]-5-methoxybenzamide

N-(5-Bromo-2-pyridinyl)-2-[[4-(imino-1-pyrrolidinylmethyl)benzoyl]amino]-5-methoxybenzamide

C25H24BrN5O3 (521.1062414)


   
   

O(6)-Methyldeoxyguanosine triphosphate

O(6)-Methyldeoxyguanosine triphosphate

C11H18N5O13P3 (521.0113968)


   

Phosphomethylphosphonic acid guanylate ester

Phosphomethylphosphonic acid guanylate ester

C11H18N5O13P3 (521.0113968)


   

6-Thioguanosine-5-O-triphosphate

6-Thioguanosine-5-O-triphosphate

C11H18N5O13P3 (521.0113968)


   

N6-Methyladenosine 5-triphosphate

N6-Methyladenosine 5-triphosphate

C11H18N5O13P3 (521.0113968)


   

6-[(5-Bromo-3-phenyl-1H-indole-2-carbonyl)-hydrazonomethyl]-2,3-dimethoxy-benzoic acid

6-[(5-Bromo-3-phenyl-1H-indole-2-carbonyl)-hydrazonomethyl]-2,3-dimethoxy-benzoic acid

C25H20BrN3O5 (521.058625)


   
   

4-(Cytidine 5-diphospho)-2-C-methyl-D-erythritol

4-(Cytidine 5-diphospho)-2-C-methyl-D-erythritol

C14H25N3O14P2 (521.081173)


   

4-cdp-2-C-methyl-D-erythritol

4-cdp-2-C-methyl-D-erythritol

C14H25N3O14P2 (521.081173)


   

3-[2-(hydroxymethyl)-3-methoxyphenyl]-2-(3-iodophenyl)-10-methyl-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one

3-[2-(hydroxymethyl)-3-methoxyphenyl]-2-(3-iodophenyl)-10-methyl-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one

C26H20INO3 (521.0487880000001)


   

3-[2-(hydroxymethyl)-3-methoxyphenyl]-2-(4-iodophenyl)-10-methyl-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one

3-[2-(hydroxymethyl)-3-methoxyphenyl]-2-(4-iodophenyl)-10-methyl-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one

C26H20INO3 (521.0487880000001)


   

[(2r,3s,4s,5s)-3,4-dihydroxy-5-(2-hydroxy-4-iminopyrimidin-1-yl)oxolan-2-yl]methoxy([hydroxy((2r,3s)-2,3,4-trihydroxy-3-methylbutoxy)phosphoryl]oxy)phosphinic acid

[(2r,3s,4s,5s)-3,4-dihydroxy-5-(2-hydroxy-4-iminopyrimidin-1-yl)oxolan-2-yl]methoxy([hydroxy((2r,3s)-2,3,4-trihydroxy-3-methylbutoxy)phosphoryl]oxy)phosphinic acid

C14H25N3O14P2 (521.081173)


   

[(2r,3s,4r,5r)-3,4-dihydroxy-5-(2-hydroxy-4-iminopyrimidin-1-yl)oxolan-2-yl]methoxy([hydroxy((2r,3s)-2,3,4-trihydroxy-3-methylbutoxy)phosphoryl]oxy)phosphinic acid

[(2r,3s,4r,5r)-3,4-dihydroxy-5-(2-hydroxy-4-iminopyrimidin-1-yl)oxolan-2-yl]methoxy([hydroxy((2r,3s)-2,3,4-trihydroxy-3-methylbutoxy)phosphoryl]oxy)phosphinic acid

C14H25N3O14P2 (521.081173)